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Summary The measurement of exhaled carbon monoxide (CO) level may provide an
immediate, non-invasive method of assessing smoking status. The aims of this study
were to use a portable CO monitor to compare the exhaled CO levels in established
smokers and non-smokers.
The exhaled CO levels were measured in 322 subjects (243 healthy smokers, 55
healthy non-smokers, 24 passive smokers) who applied to healthy stand during the
spring student activity of Fırat University in Elazı$g. Exhaled CO concentration was
measured using the EC50 Smokerlyser.
The mean exhaled CO level was 17.1378.50 parts per million (ppm) for healthy
smokers and 3.6172.15 ppm for healthy non-smokers, and 5.2073.38 ppm for
passive smokers. There were significant positive correlation between CO levels and
daily cigarette consumption, and CO levels and duration of smoking in healthy
smokers (r ¼ þ0:550; Po0:001; r ¼ þ0:265; Po0:001; respectively. Spearman’s test).
When smokers and non-smokers were looked at as a whole, a cutoff of 6.5 ppm had a
sensitivity of 90% and specificity of 83%.
In conclusion, exhaled CO level provides an easy, an immediate way of assessing a
subject’s smoking status.
& 2004 Elsevier Ltd. All rights reserved.
Introduction
For a long time now, it has been known that
smoking is associated both etiologically and pros-
tognically with numerous diseases of the respira-
tory system. However, despite this knowledge,
many subjects continue to smoke.1 Smoking habits
of patients are clinically important, for example as
a risk factor or as a reason for failure to respond to
treatment,2 and it enables appropriate antismoking
advice to be given. It has been reported that the
use of carbon monoxide (CO) monitor to demon-
strate an immediate and potentially harmful con-
sequence of smoking increased further the number
who complied with advice to quit.3
CO may play a role in pathophysiology of airway
diseases.4 CO has been recovered in exhaled air
from normal subjects and at higher levels from the
exhaled air of patients with asthma.4 Significantly
lower CO concentrations have been reported in
exhaled air from asthmatic patients receiving
glucocorticoid treatment than from asthmatic
patients not receiving this therapy.4 In contrast,
in a study by Zetterquist et al.5 it was reported that
the levels of CO in the exhaled air of the subjects
with asthma, allergic rhinitis or cystic fibrosis were
not significantly increased. Levels of CO in exhaled
air has been widely used as indication of smoking
cessation.4,6,7
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The measurement of exhaled CO level may
provide an immediate, non-invasive method of
assessing smoking status, although other sources
of pollution including exhausts gases causes eleva-
tions in the fractional concentrations of CO in
expired air.1,5 Furthermore, the development of
relatively inexpensive portable CO monitors en-
ables breath CO levels to be assessed in a wide
variety of clinical settings.1 In practice, measuring
the concentration of CO in the exhaled air, is non-
invasive, cheap, quick, portable, and does not
require special technical background.8,9
The aim of this study was to compare the breath
CO levels in established smokers and non-smokers
and to investigate factors that may affect breath
CO levels by measuring exhaled CO levels.
Methods
Three hundred and twenty-two subjects who
visited the student health club desk during the
spring student activity of Fırat University in Elazı$g
were included the study. The subjects were
informed of the purpose of the Smokerlyser and
were reassured that the results were confidential in
order to encourage accurate reporting of smoking
habits. Background information about their health,
age, gender, smoking habits, occupational state
and passive smoke was obtained. Questions about
smoking history were the same for healthy current
smokers and passive smokers. An active smoker
was defined as a person who currently smoked at
least one cigarette a day. Healthy smokers was
described as follows: all of the healthy current-
smokers subjects had normal clinical evaluation
(no respiratory symptoms) or minimal respiratory
symptoms (these symptoms varied from isolated
symptoms; cough, sputum production, dyspnea
after strenuous activity). They were detected
only by means of clinical questioning, and were
commonly considered to be normal among smo-
kers.10 Passive smoking was defined as they had
never smoked cigarettes or had stopped smoking
for at least 10 years before the date of the
interview and were not current smokers of pipes,
cigars, or cigarillos. Exposure to environmental
tobacco smoke (ETS) was ascertained using data
derived from the same questions asked to the
subjects. A person was deemed to have been
exposed to ETS if a household member had
regularly smoked cigarettes in their presence or if
a co-worker smoked in the same indoor room in
their presence for more than one year during the
past 10 years.11
Finally, all subjects were asked to provide one
breath into Smokerlyser because of a previous
study has been reported the first reading to be
significantly higher than the second as described
below.1
Breath CO monitoring
Exhaled CO concentration was measured using the
EC50 Smokerlyser (Bedfont Instruments; Kent, UK).
Bedfont EC50 analyser is reported to correlate
closely with blood carboxyhaemoglobin concentra-
tion in smokers and in non-smokers, and it is an
inexpensive, portable CO monitor that has pre-
viously been shown to be effective.9,12 Prior to the
start of the study, the analyser was calibrated with
a mixture of 50 ppm CO in air.8 The Smokerlyser
measures breath CO levels in parts per million
(ppm) based on the conversion of CO to carbon
dioxide (CO2) over a catalytically active electrode.
1
The measurement of exhaled CO was done at
students health club desk which was placed in an
open air at University exhibition field. To standar-
dize the breath being analyzed by the Smokerlyser,
the subjects are asked to exhale completely, inhale
fully, and then hold their breath for 15 s before
exhaling rapidly into disposable mouthpiece. Am-
bient CO levels were recorded before each breath.
Statistical analysis
All statistical analyses were done using SPSS v10.0
software. Results were expressed as mean7SD.
ANOVA was used to compare all exhaled CO levels
between groups and LSD test was used depending
on sample distribution. A value of P less than 0.05
was considered significant. Spearman correlation
analyses were used to evaluate the relationship
between the exhaled CO levels-daily cigarette
consumption, and CO levels-duration of smoking
in healthy smokers.
Results
Exhaled CO was detectable in all subjects. Ambient
air concentrations of CO were at 0–2 ppm level
during the measurements.
Breath CO levels were assessed in a total of
322 subject; 243 of them was healthy smokers
(224 men; 19 women; mean age 24.6975.89),
55 of them was healthy non-smokers (46 men; 9
women; mean age 22.3075.27) and 24 of them was
passive smokers (21 men; 3 women; mean age
27.2079.15).
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For the smokers, the mean daily consumption of
cigarettes was 19.7979.04 cigarettes/d and all of
them reported that they had smoked on the day of
testing.
The mean exhaled CO level was 17.1378.50 ppm
for healthy smokers and 3.6172.15 ppm for healthy
non-smokers, and 5.2073.38 ppm for passive
smokers. The mean exhaled CO level was signifi-
cantly higher in healthy smokers than healthy non-
smokers (Po0:001) and passive smokers (Po0:001).
The mean exhaled CO level was higher in passive
smokers than healthy non-smokers but not signifi-
cant (P40:05) (Fig. 1).
There was a significant positive correlation
between CO levels and daily cigarette consump-
tion, and CO levels and duration of smoking in
healthy smokers (r ¼ þ0:550; Po0:001; r ¼ þ0:265;
Po0:001; respectively. Spearman’s test) (Figs. 2A
and B).
A CO level of 6.5 ppm was taken as the cutoff
between healthy smokers and non-smokers, as it
gave the highest sensitivity and specificity. When
smokers and non-smokers were looked at as a
whole, a cutoff of 6.5 ppm had a sensitivity of 90%
and specificity of 83% (ROC curve) (Fig. 3).
Discussion
There are several methods of assessing smoking
status. Nicotine, cotinine, or thiocyanate levels in
the plasma or urine may be used to indicate
smoking status.13 However, the blood tests are
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Figure 2 Correlation between exhaled CO levels and the
number of cigarettes smoked in day (A), and exhaled CO
levels and duration of smoking in healthy smokers (B).
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Figure 3 A cutoff level of CO in healthy smokers and
non-smokers.
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Figure 1 CO concentrations in exhaled air in healthy
smokers (n ¼ 243), healthy non-smokers (n ¼ 55), and
passive smokers (n ¼ 24).
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invasive and neither the blood nor the urine test
provide an immediate assessment. The measure-
ment of breath CO level may provide an immedi-
ate, non-invasive method of assessing smoking
status.1 This study supports that measuring breath
CO levels provides an immediate, non-invasive,
simple, and effective way of confirming a patients’s
smoking status.
Exhaled CO levels were higher in healthy smokers
than in healthy non-smokers.1,14 Also in our study,
the exhaled CO level with the Smokerlyser was
significantly higher in healthy smokers than healthy
non-smokers and the values of exhaled CO in
smoking and non-smoking subjects were similar to
those of previous study.1,14 There is a direct
relationship between the smoking status of a
given individual and the concentration of carbox-
yhaemoglobin (COHb) in their blood.15,16 Exhaled
CO reflects COHb accurately only if the lung acts as
an effective tonometer, and exhaled CO is in
dynamic equilibrium with COHb.15 The measure-
ment of exhaled CO is widely used to estimate
COHb and, as such, to monitor the smoking
habits of patients.9,17,18 Considering that a COHb
concentration X2% is generally used in the
clinical arena to separate smokers from non-
smokers.19 Our results shown that exhaled CO
levels may be used to distinguish smokers from
non-smokers as same as the others. Jarvis et al.13
reported that CO measures as blood carboxyhae-
moglobin or in expired as gave sensitivity and
specifity of about 90% for distinguish smokers from
non-smokers.
Our results shown that there was a significantly
positive correlation between daily consumption of
cigarettes and CO levels, and between duration of
smoking and CO levels in healthy smokers. Likewise
Gonzalez et al.20 reported that CO in expired air
correlated significantly with the number of smoked
cigarettes. Smokers who develop chronic obstruc-
tive pulmonary disease, besides consuming a great-
er number of cigarettes, smoke them with a
particular inhalation pattern (they inhale a greater
volume of smoke and more deeply), thus permitting
a higher quantity of oxidant substances.21 Cunning-
ton et al.22 demonstrated that the mean breath CO
concentrations increased in direct proportion to
the number of cigarettes smoked.
Any exposure to CO may occur in normal day-to-
day life, due to environmental pollution, passive
smoking, and occupational exposure, the most
likely cause of high levels of exposure is smoking.23
Another cause of high levels of CO exposure is
occult CO poisoning, for example, due to a faulty
automobile exhaust system or home heating sys-
tem, although this is only likely to be responsible
for a minority of cases of raised breath CO levels.1
CO in expired air has been reported to be an
indirect measurement for the quantity of passive
smoking24 and exhaled CO can be used as an
indicator of indoor smoking.25 In our study, the
exhaled CO levels was 5.20 ppm in passive smokers.
Laranjeira et al.26 reported that exposure to
environmental tobacco smoke is the most likely
cause for the increase in CO levels among non-
smoking waiters. In this study it is reported that
pre-exposure exhaled CO level was 2.0 ppm and
post-exposure exhaled CO level was 5.0 ppm. In our
study, 9 of passive smokers (n ¼ 24) were working
in the university canteen which has indoor smoking
place. Moreover, 15 of passive smokers were
students and they explained that they usually
spend their free time at this university canteen.
As expected passive smokers had higher CO
concentration than healthy non-smokers, but this
elevation was not significant. In a previous studies,
the mean exhaled CO concentrations was usually
similar in healthy non-smokers. For example,
exhaled CO levels were determined 1.570.1 ppm
in Zayasu et al.4 study, 1.270.9 ppm in Yamaya
et al.27 study and 1.270.3 ppm in Yamaya et al.6
study. In our study, the exhaled CO levels was
3.61 ppm in healthy non-smokers. These results
were high compared with other studies results. This
may be due to excessive environmental pollution,
faulty automobile exhaust system, and home
heating system in our city.
Our results shown that the optimal cutoff was
6.5 ppm, giving 90% sensitivity and 83% specificity.
Similarly Middleton and Morice1 reported that the
optimal cutoff was 6 ppm (selectivity 96%, sensi-
tivity 94%). Jarvis et al.13 reported that the optimal
cutoff was 8 ppm (sensitivity 90%, selectivity 89%),
and Crowley et al.28 also reported that a breath CO
level 48 ppm was strongly associated with a self
report of current smoking. When exhaled CO at
7 ppm or over differentiated ‘‘smokers’’ from ‘‘non-
smokers’’, sensitivity was 93% and specificity was
95% for detecting smokers.29 Likewise Hewat
et al.30 shown that exhaled CO levels were all
below 7 ppm, within the normal range for non-
smokers. Many studies using breath CO monitors
have tended use 10 ppm as the cutoff.31,32 In our
study, when we take the cutoff was 10.5 ppm,
giving 75% sensitivity and 98% specificity. This
results suggest that 10.5 ppm is too high to be a
cutoff for a screening test, as it will reduce its
sensitivity.
Jarvis et al.9 shown that the second breath CO
level was significantly higher than the first.
In contrast Middleton and Morice1 reported that
the first breath CO level was significantly
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higher than the second and they recommended
that a single Smokerlyser assessment should usually
be sufficient, provided that there is adequate
technique. For this reason in present study
exhaled CO levels were assessment with the first
measurement.
In clinical practice, it would be important to
ensure the Smokerlyser was calibrated regularly.
This was not a problem in this study because of the
measurements were done in 5 days at the open air
near the student healthy club desk after the
Smokerlyser calibrated. Moreover we think that
exhaled CO level likely is not affected the ambient
air because of the measurements were done at the
open air.
In a previous study it was stated that exhaled CO
may be affected by ambient CO and that this
influence may be reduced by subtracting ambient
CO from exhaled CO.33 In contrast, Zetterquist
et al.’s5 study shown that ambient air did not affect
the exhaled CO levels when subjects held their
breath for 10 s. Since there seems to be no
contribution of CO from the conducting airways it
must have its origin from the alveoli. The increase
in CO concentrations after breath-hold also sup-
ports this view. The inhaled CO concentration may
affect the concentration gradient of CO over the
alveolar membranes (and possibly in the airways),
and should not be compensated for by direct
subtraction. A standardised time of breath-hold of
15 s was used in all the experiments which should
have been sufficient for equilibrium to take place.5
Since we also ask to the subjects to hold their
breath for 15 s we did not consider the impact of
ambient air.
In conclusion, exhaled CO measurements may
provide a non-invasive, sensitive, and immediate
way of assessing a patient’s smoking status. CO
measurement will replace at some stage the usual
question regarding the number of cigarettes con-
sumed. Moreover exhaled CO level is recommended
for evaluating the exposure of passive smoking.
Determining of exhaled CO level46.5 ppm strongly
suggests that subject is a smoker.
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